{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:17:33Z","timestamp":1790810253254,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.euf.2016.05.004","type":"journal-article","created":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T06:16:41Z","timestamp":1464934601000},"page":"212-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer"],"prefix":"10.1016","volume":"3","author":[{"given":"Teemu J.","family":"Murtola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti I.","family":"Peltomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsi","family":"Talala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liisa","family":"M\u00e4\u00e4tt\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimmo","family":"Taari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teuvo L.J.","family":"Tammela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anssi","family":"Auvinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2016.05.004_bib0115","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ncpuro1146","article-title":"Statins and prostate cancer prevention: where we are now, and future directions","volume":"5","author":"Murtola","year":"2008","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.euf.2016.05.004_bib0120","doi-asserted-by":"crossref","first-page":"e46691","DOI":"10.1371\/journal.pone.0046691","article-title":"Statin use and risk of prostate cancer: A meta-analysis of observational studies","volume":"7","author":"Bansal","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.euf.2016.05.004_bib0125","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/annonc\/mdt077","article-title":"Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: A systematic review and meta-analysis","volume":"24","author":"Park","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euf.2016.05.004_bib0130","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1002\/cncr.26720","article-title":"Statin use and fatal prostate cancer: A matched case-control study","volume":"118","author":"Marcella","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.euf.2016.05.004_bib0135","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJMoa1201735","article-title":"Statin use and reduced cancer-related mortality","volume":"367","author":"Nielsen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2016.05.004_bib0140","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/pros.22671","article-title":"Statin use in relation to prostate cancer outcomes in a population-based patient cohort study","volume":"73","author":"Geybels","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.euf.2016.05.004_bib0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1200\/JCO.2013.49.4757","article-title":"Use of statins and the risk of death in patients with prostate cancer","volume":"32","author":"Yu","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2016.05.004_bib0150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/pcan.2015.58","article-title":"Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis","volume":"19","author":"Raval","year":"2016","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euf.2016.05.004_bib0155","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1158\/1055-9965.EPI-15-0671","article-title":"Postdiagnostic statin use and the risk of lethal prostate cancer in the health professionals follow-up study","volume":"24","author":"Chan","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.euf.2016.05.004_bib0160","first-page":"7703","article-title":"Influence of statin use on clinicopathological characteristics of localized prostate cancer and outcomes obtained after radical prostatectomy: A single center study","volume":"22","author":"Cattarino","year":"2015","journal-title":"Can J Urol"},{"key":"10.1016\/j.euf.2016.05.004_bib0165","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/jnci\/djt038","article-title":"Prostate cancer mortality in the Finnish Randomized Screening Trial","volume":"105","author":"Kilpel\u00e4inen","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euf.2016.05.004_bib0170","unstructured":"Mottet N, Bellmunt J, Briers E, et al. Guidelines on prostate cancer 2015. European Association of Urology Website. http:\/\/uroweb.org\/wp-content\/uploads\/09-Prostate-Cancer_LR.pdf"},{"key":"10.1016\/j.euf.2016.05.004_bib0175","first-page":"1","article-title":"Drug reimbursement systems in EU Member States, Iceland and Norway","volume":"54","author":"Martikainen","year":"2002","journal-title":"Helsinki: The Social Insurance Institution, Finland, Social security and health reports"},{"key":"10.1016\/j.euf.2016.05.004_bib0180","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. ATC\/DDD Index 2013. 2013. http:\/\/www.whocc.no\/atc_ddd_index\/"},{"key":"10.1016\/j.euf.2016.05.004_bib0185","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamaoncol.2015.0829","article-title":"Statin use at the time of initiation of androgen deprivation therapy and time to progression in patients with hormone-sensitive prostate cancer","volume":"1","author":"Harshman","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euf.2016.05.004_bib0190","first-page":"219","article-title":"Cholesterol accumulation in prostate cancer: A classic observation from a modern perspective","volume":"1835","author":"Krycer","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.euf.2016.05.004_bib0195","doi-asserted-by":"crossref","first-page":"e39445","DOI":"10.1371\/journal.pone.0039445","article-title":"The importance of LDL and cholesterol metabolism for prostate epithelial cell growth","volume":"7","author":"Murtola","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.euf.2016.05.004_bib0200","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2011.10.022","article-title":"Comparative effects of high and low-dose simvastatin on prostate epithelial cells: The role of LDL","volume":"673","author":"Murtola","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.euf.2016.05.004_bib0205","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1158\/1055-9965.EPI-09-1074","article-title":"Association between statins and prostate tumor inflammatory infiltrate in men undergoing radical prostatectomy","volume":"19","author":"Banez","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.euf.2016.05.004_bib0210","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/j.1464-410X.2012.11445.x","article-title":"Targeting the androgen receptor signaling axis in castration-resistant prostate cancer (CRPC)","volume":"110","author":"Tsao","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2016.05.004_bib0215","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1158\/1055-9965.EPI-08-1248","article-title":"Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer","volume":"18","author":"Ahn","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.euf.2016.05.004_bib0220","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/aje\/kwm070","article-title":"Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect","volume":"166","author":"Brookhart","year":"2007","journal-title":"Am J Epidemiol"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456916300529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456916300529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:46:23Z","timestamp":1762497983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456916300529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":22,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S2405456916300529"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2016.05.004","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2016.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}